NCT01109485View on ClinicalTrials.gov

Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Allergic Conjunctivitis
Interventions
DRUG

Olopatadine hydrochloride ophthalmic solution 0.1%

1-2 drops 4 times per day

Trial Locations (1)

1F

Contact Alcon Call Center For Trial Locations, Tokyo

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY